Abstract
Hypophosphatasia (HPP) is a rare inborn, metabolic bone disorder caused by mutations in the tissue-nonspecific alkaline phosphatase-encoding gene: ALPL. The diagnosis is based on biochemical, clinical and genetic evaluation. Low levels of alkaline phosphatase is a hallmark in diagnosing HPP. Mild forms may present unspecific symptoms and be more frequent than previously assumed. Adults with HPP may present with low bone mass, however, bisphosphonates are contra-indicated for these patients. Finally, enzyme replacement therapy has opened new therapeutic perspectives regarding severe HPP.
| Translated title of the contribution | Diagnostics and treatment of hypophosphatasia |
|---|---|
| Original language | Danish |
| Journal | Ugeskrift for Laeger |
| Volume | 10 |
| Pages (from-to) | 2-6 |
| Number of pages | 5 |
| ISSN | 0041-5782 |
| Publication status | Published - 13 May 2019 |
Fingerprint
Dive into the research topics of 'Diagnostics and treatment of hypophosphatasia'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS